These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 33709785)

  • 21. Biomarker-based risk prediction in the community.
    AbouEzzeddine OF; McKie PM; Scott CG; Rodeheffer RJ; Chen HH; Michael Felker G; Jaffe AS; Burnett JC; Redfield MM
    Eur J Heart Fail; 2016 Nov; 18(11):1342-1350. PubMed ID: 27813304
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prediction of incident heart failure by serum amino-terminal pro-B-type natriuretic peptide level in a community-based cohort.
    Campbell DJ; Gong FF; Jelinek MV; Castro JM; Coller JM; McGrady M; Boffa U; Shiel L; Wang BH; Liew D; Wolfe R; Stewart S; Owen AJ; Krum H; Reid CM; Prior DL
    Eur J Heart Fail; 2019 Apr; 21(4):449-459. PubMed ID: 30656792
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Echocardiography, natriuretic peptides, and risk for incident heart failure in older adults: the Cardiovascular Health Study.
    Kalogeropoulos AP; Georgiopoulou VV; deFilippi CR; Gottdiener JS; Butler J;
    JACC Cardiovasc Imaging; 2012 Feb; 5(2):131-40. PubMed ID: 22340818
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic value of C-reactive protein as an inflammatory and N-terminal probrain natriuretic peptide as a neurohumoral marker in acute heart failure (from the Korean Heart Failure registry).
    Park JJ; Choi DJ; Yoon CH; Oh IY; Jeon ES; Kim JJ; Cho MC; Chae SC; Ryu KH; Yoo BS; Kang SM; Oh BH;
    Am J Cardiol; 2014 Feb; 113(3):511-7. PubMed ID: 24315115
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Molar Ratio of N-terminal pro-B-type Natriuretic Peptide/B-type Natriuretic Peptide for Heart Failure-related Events in Stable Outpatients with Cardiovascular Risk Factors.
    Suzuki S; Sugiyama S
    Intern Med; 2018 Sep; 57(18):2621-2630. PubMed ID: 29709934
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term pattern of brain natriuretic peptide and N-terminal pro brain natriuretic peptide and its determinants in the general population: contribution of age, gender, and cardiac and extra-cardiac factors.
    Luchner A; Behrens G; Stritzke J; Markus M; Stark K; Peters A; Meisinger C; Leitzmann M; Hense HW; Schunkert H; Heid IM
    Eur J Heart Fail; 2013 Aug; 15(8):859-67. PubMed ID: 23568644
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Insulin resistance is associated with increased concentrations of NT-proBNP in rheumatoid arthritis: IL-6 as a potential mediator.
    Bradham WS; Ormseth MJ; Oeser A; Solus JF; Gebretsadik T; Shintani A; Stein CM
    Inflammation; 2014 Jun; 37(3):801-8. PubMed ID: 24402421
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic value of baseline plasma amino-terminal pro-brain natriuretic peptide and its interactions with irbesartan treatment effects in patients with heart failure and preserved ejection fraction: findings from the I-PRESERVE trial.
    Anand IS; Rector TS; Cleland JG; Kuskowski M; McKelvie RS; Persson H; McMurray JJ; Zile MR; Komajda M; Massie BM; Carson PE
    Circ Heart Fail; 2011 Sep; 4(5):569-77. PubMed ID: 21715583
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Physical activity in older men: longitudinal associations with inflammatory and hemostatic biomarkers, N-terminal pro-brain natriuretic peptide, and onset of coronary heart disease and mortality.
    Jefferis BJ; Whincup PH; Lennon LT; Papacosta O; Goya Wannamethee S
    J Am Geriatr Soc; 2014 Apr; 62(4):599-606. PubMed ID: 24635212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of ivabradine therapy on heart failure biomarkers.
    Ordu S; Yildiz BS; Alihanoglu YI; Ozsoy A; Tosun M; Evrengul H; Kaftan HA; Ozhan H
    Cardiol J; 2015; 22(5):501-9. PubMed ID: 25733317
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic relevance of baseline pro- and anti-inflammatory markers in STEMI: an APEX AMI substudy.
    van Diepen S; Newby LK; Lopes RD; Stebbins A; Hasselblad V; James S; Roe MT; Ezekowitz JA; Moliterno DJ; Neumann FJ; Reist C; Mahaffey KW; Hochman JS; Hamm CW; Armstrong PW; Granger CB; Theroux P;
    Int J Cardiol; 2013 Oct; 168(3):2127-33. PubMed ID: 23394896
    [TBL] [Abstract][Full Text] [Related]  

  • 32. NT-proB natriuretic peptide, risk factors and asymptomatic left ventricular dysfunction: results of the SCReening Evaluation of the Evolution of New Heart Failure study (SCREEN-HF).
    McGrady M; Reid CM; Shiel L; Wolfe R; Boffa U; Liew D; Campbell DJ; Prior D; Stewart S; Krum H
    Int J Cardiol; 2013 Oct; 169(2):133-8. PubMed ID: 24080362
    [TBL] [Abstract][Full Text] [Related]  

  • 33. N-terminal Pro B-type Natriuretic Peptide and High-sensitivity Cardiac Troponin as Markers for Heart Failure and Cardiovascular Disease Risks According to Glucose Status (from the Multi-Ethnic Study of Atherosclerosis [MESA]).
    Nguyen K; Fan W; Bertoni A; Budoff MJ; Defilippi C; Lombardo D; Maisel A; Szklo M; Wong ND
    Am J Cardiol; 2020 Apr; 125(8):1194-1201. PubMed ID: 32106929
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardio-adipose tissue cross-talk: relationship between adiponectin, plasma pro brain natriuretic peptide and incident heart failure.
    Lindberg S; Jensen JS; Bjerre M; Pedersen SH; Frystyk J; Flyvbjerg A; Mogelvang R
    Eur J Heart Fail; 2014 Jun; 16(6):633-8. PubMed ID: 24723498
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study.
    Jia X; Buckley L; Sun C; Al Rifai M; Yu B; Nambi V; Virani SS; Selvin E; Matsushita K; Hoogeveen RC; Coresh J; Shah AM; Ballantyne CM
    Eur J Prev Cardiol; 2023 Nov; 30(16):1731-1740. PubMed ID: 37306504
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The prognostic value of N-terminal pro-B-type natriuretic peptide for death and cardiovascular events in healthy normal and stage A/B heart failure subjects.
    McKie PM; Cataliotti A; Lahr BD; Martin FL; Redfield MM; Bailey KR; Rodeheffer RJ; Burnett JC
    J Am Coll Cardiol; 2010 May; 55(19):2140-7. PubMed ID: 20447539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biomarkers for characterization of heart failure - Distinction of heart failure with preserved and reduced ejection fraction.
    Sinning C; Kempf T; Schwarzl M; Lanfermann S; Ojeda F; Schnabel RB; Zengin E; Wild PS; Lackner KJ; Munzel T; Blankenberg S; Wollert KC; Zeller T; Westermann D
    Int J Cardiol; 2017 Jan; 227():272-277. PubMed ID: 27838133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic utility of MR-proANP and NT-proBNP in elderly outpatients with a high risk of heart failure: the Copenhagen heart failure risk study.
    Gaborit FS; Kistorp C; Kümler T; Hassager C; Tønder N; Iversen K; Hansen PM; Kamstrup PR; Faber J; Køber L; Schou M
    Biomarkers; 2020 May; 25(3):248-259. PubMed ID: 32126847
    [No Abstract]   [Full Text] [Related]  

  • 39. Assessment of conventional cardiovascular risk factors and multiple biomarkers for the prediction of incident heart failure and atrial fibrillation.
    Smith JG; Newton-Cheh C; Almgren P; Struck J; Morgenthaler NG; Bergmann A; Platonov PG; Hedblad B; Engström G; Wang TJ; Melander O
    J Am Coll Cardiol; 2010 Nov; 56(21):1712-9. PubMed ID: 21070922
    [TBL] [Abstract][Full Text] [Related]  

  • 40. N-terminal pro-brain natriuretic peptide, C-reactive protein, and urinary albumin levels as predictors of mortality and cardiovascular events in older adults.
    Kistorp C; Raymond I; Pedersen F; Gustafsson F; Faber J; Hildebrandt P
    JAMA; 2005 Apr; 293(13):1609-16. PubMed ID: 15811980
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.